Glaxo-SmithKline merger - Companies to combine skills for new drug discovery

被引：0

|

作者：

Fox, S

机构：

来源：

GENETIC ENGINEERING NEWS | 2000年 / 20卷 / 03期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：1 / +

相关论文

共 7 条

[1] Glaxo-SmithKline merger has AGA overtones
Gordon, D
[J]. GASTROENTEROLOGY, 2000, 118 (03) : 460 - 460
[2] BEECHAM-SMITHKLINE MERGER WILL CREATE NEW DRUG GIANT
不详
[J]. MANUFACTURING CHEMIST, 1989, 60 (05): : 17 - 17
[3] The importance of new companies for drug discovery: origins of a decade of new drugs
Robert Kneller
[J]. Nature Reviews Drug Discovery, 2010, 9 : 867 - 882
[4] The importance of new companies for drug discovery: origins of a decade of new drugs
Kneller, Robert
[J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (11) : 867 - 882
[5] Erratum: The importance of new companies for drug discovery: origins of a decade of new drugs
Robert Kneller
[J]. Nature Reviews Drug Discovery, 2010, 9 (12) : 955 - 955
[6] The importance of new companies for drug discovery: origins of a decade of new drugs (vol 9, pg 867, 2010)
Kneller, Robert
[J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (12)
[7] Need of the Regulation for Profit Percentage Investment by Pharmaceutical Companies in New Drug Discovery Research from the Various Local Traditional Medicinal and Plant Systems
Bhattarai, M. D.
[J]. JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2012, 52 (03) : 148 - 150